Sep 22 2026 Freshfields advised AbbVie on its multi-year collaboration with Iambic, a clinical-stage life sciences and technology company developing novel medicines through its AI-driven discovery and development platform, to accelerate the discovery and development of small molecule therapies with first-in-class and best-in-class potential across immunology, neuroscience, and oncology.
Jimmy Cao
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Jimmy
Contact Jimmy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack